EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prolonged benzodiazepine use in clinical practice: Dependence, cognitive deficits, and challenges in tapering

João Pedro Pereira Beretta, Luiza Freitas Pena Oliveira, Eliege Bortolini, Jamile Zampieri Fernandes

International Health Sciences Review · 17.03.2026 · 2 (2)

DOI: 10.70164/ihsr.v2i2.139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 17.03.2026. Verfasst von João Pedro Pereira Beretta und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzodiazepines remain widely prescribed for anxiety, insomnia, agitation, and other short-term clinical indications because of their rapid onset and reliable symptomatic relief. However, a substantial gap persists between guideline recommendations, which generally restrict use to brief periods, and real-world prescribing patterns, where continuous use often extends for months or years. This integrative narrative review examines the pharmacological basis of tolerance and dependence, the neurocognitive and functional consequences of prolonged exposure, and the principal strategies for safe discontinuation. A bibliographic search was conducted in PubMed, SciELO, and the Cochrane Library using descriptors related to benzodiazepines, cognitive impairment, withdrawal, and tapering, with emphasis on clinical guidelines, systematic reviews, meta-analyses, and randomized trials. The evidence indicates that long-term use is associated with physiological dependence, withdrawal syndromes, psychomotor impairment, falls, and measurable deficits in memory, attention, and processing speed, especially in older adults. Although the association with dementia remains debated, the cumulative burden of adverse outcomes is clinically significant. Gradual, individualized tapering, sometimes aided by substitution with a longer-acting benzodiazepine, remains the cornerstone of management. Non-pharmacological interventions, particularly cognitive behavioral therapy for insomnia and anxiety, improve discontinuation outcomes. Rational prescribing, periodic reassessment, and structured deprescribing protocols are essential to reduce iatrogenesis and improve patient safety.

Zitieren

APA

Beretta, J. P. P., Oliveira, L. F. P., Bortolini, E., & Fernandes, J. Z. (2026). Prolonged benzodiazepine use in clinical practice: Dependence, cognitive deficits, and challenges in tapering. International Health Sciences Review, 2(2). https://doi.org/10.70164/ihsr.v2i2.139

Vancouver

Beretta JPP, Oliveira LFP, Bortolini E, Fernandes JZ. Prolonged benzodiazepine use in clinical practice: Dependence, cognitive deficits, and challenges in tapering. International Health Sciences Review. 2026;2(2). doi:10.70164/ihsr.v2i2.139

BibTeX
@article{Beretta2026,
  author = {Beretta, João Pedro Pereira and Oliveira, Luiza Freitas Pena and Bortolini, Eliege and Fernandes, Jamile Zampieri},
  title = {Prolonged benzodiazepine use in clinical practice: Dependence, cognitive deficits, and challenges in tapering},
  journal = {International Health Sciences Review},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.70164/ihsr.v2i2.139}
}
Kostenlos starten →